Search Results 221-230 of 17353 for LDL

  1. Publications - Chris Hartley, M.D. - Mayo Clinic

    ... LDL receptor. Sci Rep. 2023 Oct 6; 13 (1):16832 Epub 2023 Oct 06. View PubMed; Ricaurte Archila L, Smith L, Sihvo HK, Koponen V, Jenkins SM, O'Sullivan DM ...

  2. Publications - Balaji Tamarappoo, M.D., Ph.D. - Mayo Clinic

    Decrease in LDL-C is associated with decrease in all components of noncalcified plaque on coronary CTA. Atherosclerosis. 2019 Jun; 285:128-134 Epub 2019 Apr ...

  3. A Study to Improve the Use of Genetic Testing in Disease Prevention and Clinical Care and to Further Understand Types of Genetic Differences that May Cause Disease - Mayo Clinic

    Current participant in the Sangre Por Salud Biobank, Mountain Park Health Center, Phoenix, Arizona (IRB#12-008503) · Dyslipidemia with. Hypercholesterolemia. LDL ...

  4. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  5. Colesterol e seu tratamento: Um novo enfoque de aplicação - Mayo Clinic News Network

    São prescritas para pessoas com mais de 21 anos e menos de 75, com doença cardiovascular diagnosticada clinicamente, pessoas com colesterol LDL igual ou ...

  6. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

    Mayo Clinic investigators are making new discoveries in the areas of cause, prevention and treatment of NAFLD . Their findings are helping to improve patient ...

  7. Tricuspid valve disease - Doctors and departments - Mayo Clinic

    This condition affects the valve between the two right heart chambers. It can change the way blood flows through the heart. Learn about the different types.

  8. High cholesterol - Doctors and departments - Mayo Clinic

    The body needs some cholesterol to build healthy cells. But high cholesterol can raise the risk of heart disease. Lifestyle changes can help.

  9. A Study to Evaluate the Safety and Effectiveness of Obeticholic Acid Treatment on People with Non-Alcoholic Steatohepatitis with Fibrosis - Mayo Clinic

    LDL ≥ 190 mg/dL and already on a stable dose of statin and/or proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor for ≥ 30 days at Screening.

  10. Sleep disorders - Doctors and departments - Mayo Clinic

    ... LDL apheresis. Richard L. Godby, M.D.. Hematologist. Rochester, MN. Areas of focus: Bone marrow biopsy and aspiration, Platelet ...